BackEmergent Biosolutions Overview
Emergent Biosolutions Inc

Emergent Biosolutions Target Price

Where could EBS trade next? Consensus target price: $10.

Get informed when a big investor buys or sells

+ Follow

Share Price

$5.89

Average Target Price

$10.0069.9% upside

1 analysts in the last 4 months

High: $10 | Low: $10

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-10H.C. Wainwright$1069.9% upsideOpen
2026-03-09H.C. Wainwright$12103.9% upsideOpen
2022-05-04Wells Fargo$38545.7% upsideOpen
2022-04-29Chardan Capital$651004.5% upsideOpen

Emergent Biosolutions (EBS) FAQ

The latest target price for EBS is $10. Investors often review this figure alongside Emergent Biosolutions's historical trend and sector peers before judging valuation or financial health.

Emergent Biosolutions trades near $5.89 while the consensus target sits at $10 (69.9% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting EBS's target price ($10), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Emergent Biosolutions's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.